Marshall Wace’s SkinHealth Systems SKIN Stock Holding History

Marshall Wace’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Buy	192,373 +160,694	+507%	+$123K	﹤0.01%	2891
2026 Q1	$28.2K	Buy	+31,679	New	+$38.9K	﹤0.01%	3024
2025 Q4	–	Sell	-23,799	Closed	-$47.4K	–	3434
2025 Q3	$47.4K	Buy	+23,799	New	+$48.3K	﹤0.01%	2734
2022 Q4	–	Sell	-1,177,732	Closed	-$13.9M	–	3377
2022 Q3	$13.9M	Buy	1,177,732 +1,160,932	+6,910%	+$14.7M	0.03%	640
2022 Q2	$217K	Sell	16,800 -1,249,085	-99%	-$16.7M	﹤0.01%	3147
2022 Q1	$21.4M	Sell	1,265,885 -1,762,053	-58%	-$29.1M	0.04%	471
2021 Q4	$73.2M	Sell	3,027,938 -1,085,492	-26%	-$28M	0.14%	141
2021 Q3	$107M	Buy	+4,113,430	New	+$90.5M	0.44%	24
2021 Q2	–	Sell	-17,432	Closed	-$188K	–	3048
2021 Q1	$188K	Sell	17,432 -476,669	-96%	-$5.24M	﹤0.01%	2280
2020 Q4	$5.59M	Buy	+494,101	New	+$5.32M	0.03%	529

Other funds holding SKIN

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marshall Wace's SKIN Position: Q2 2026 in Review

Marshall Wace increased its SkinHealth Systems (SKIN) stake by 507% in Q2 2026, buying an estimated $123K and bringing the position to 192,373 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #2891.

Marshall Wace first reported a position in SKIN in Q4 2020 and has held it in 10 quarters since. The position peaked at $107M in Q3 2021. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

Marshall Wace held 192,373 shares of SkinHealth Systems worth $133K as of Q2 2026.
Marshall Wace bought 160,694 SkinHealth Systems shares in Q2 2026, an estimated $123K.
SkinHealth Systems made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2891 holding.
Marshall Wace first reported a position in SkinHealth Systems in Q4 2020 and has held it in 10 quarters since.
Marshall Wace's SkinHealth Systems position peaked at $107M in Q3 2021.
96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.